UNC-Malawi cancer pathology laboratory is a model for Sub-Saharan Africa

August 8, 2013, University of North Carolina Health Care

Since 2011, the University of North Carolina has partnered with the government of Malawi to establish a pathology laboratory in the nation's capital, building on an existing decades-long collaboration. The laboratory has provided an invaluable service to patients and has also built capacity at a national teaching hospital, according to an analysis of the first 20 months of operation published online by PLOS ONE.

"A robust platform for and research now exists in a setting where it did not previously, and can serve as a model for similar interventions throughout sub-Saharan Africa," said Dr. Satish Gopal, MD, MPH, study author and member of the UNC Lineberger Comprehensive Cancer Center's Global Oncology Program.

In July of 2011, UNC and the Malawi Ministry of Health established a pathology laboratory at Kamuzu Central Hospital in Malawi's capital city of Lilongwe. Relying on a largely Malawian staff (Fred Chimzimu, Coxcilly Kampani, Prof. George Liomba), supported by UNC collaborators, the lab has now assessed more than 3,600 specimens.

The lab became one of only two pathology labs in the nation of 16 million, helping to relieve diagnostic delays that contributed to late diagnoses and early deaths for Malawians suffering from . Cancer has become a growing health problem in Sub-Saharan African countries like Malawi, with disease rates more than doubling since 1999 due to factors such as HIV which increases risk of many cancers, population aging, and the widespread adoption of Westernized lifestyles,.

Importantly, staffing of the Malawi laboratory relies on Malawians, including Prof. George Liomba, a senior Malawian pathologist formerly with the College of Medicine in Blantyre, who has analyzed more than 95 percent of specimens after joining UNC full-time in 2012. While telemedicine technology purchased by UNC Lineberger has allowed for weekly consultations between the Malawi lab and UNC pathologists and physicians in North Carolina, Dr. Gopal said that the early experience has shown that a sustainable laboratory must rely on Malawian health care workers.

"Telepathology has been an important tool for collaboration, rather than a primary mode by which diagnostic interpretation are rendered. Importantly, it cannot be a substitute for training a sufficient number of Malawian pathologists and laboratory technicians to provide essential diagnostic services," said Dr. Gopal. In this regard, UNC has directly supported the training of technicians abroad who have now returned to Lilongwe to staff the lab.

Sustainability will be a major focus for the laboratory in the coming years, according to Dr. Gopal. Beyond the need for training local staff and physicians, the laboratory is developing locally appropriate fee schedules, and starting to provide diagnostic services to hospitals in surrounding areas outside Lilongwe. While external funds can provide the necessary support for training and equipping cancer facilities in the region, the ultimate goal must be independence from external support.

Additionally, the expansion of a cancer workforce in Africa is crucial, as the projected burden of cancer will continue to rise in the region. Pathology laboratories such as the UNC-Malawi partnership can begin the process of collecting data to allow governments to have a fuller picture of the prevalence of cancer in the region, in order to guide cancer control efforts at the local level.

Explore further: Half million Malawians on free AIDS drugs: president

Related Stories

Half million Malawians on free AIDS drugs: president

June 28, 2013
Malawi is distributing free AIDS drugs to half a million people after years of nationwide HIV tests by the poor southern African nation, President Joyce Banda said Friday.

RNA diagnostic test from paraffin improves lung cancer diagnosis over routine microscopic evaluation

July 16, 2013
Knowing what type of lung cancer a patient has is critical to determine which drug will work best and which therapies are safest in the era of personalized medicine. Key to making that judgment is an adequate tumor specimen ...

Cervical cancer screening in less-developed areas should be tailored to local conditions

January 14, 2013
The best approach to detecting cervical cancer in HIV-positive women living in research limited countries such as those in Sub-Saharan Africa combines commonly used testing methods tailored to local levels of development ...

Longer breastfeeding along with antiretroviral drugs could lower HIV transmission to babies

April 25, 2012
In early results of a large-scale randomized study published in 2010 and led by researchers from the University of North Carolina at Chapel Hill, giving daily antiretroviral drugs (ART) to HIV-infected moms or their breastfeeding ...

Eligibility for aspirin for primary prevention in men increases when cancer mortality benefit added

June 6, 2013
While aspirin has been shown to be effective in preventing heart attacks in men, it also increases the risk of gastrointestinal bleeding and possibly stroke, even at low doses. As such, national guidelines suggest that aspirin ...

Hematologic malignancies rapidly increasing and unaddressed in Sub-Saharan Africa

April 4, 2012
(Medical Xpress) -- Sub-Saharan Africa is experiencing a growing cancer burden, and hematologic malignancies account for almost 10 percent of cancer deaths in the region.  In the United States and other resource-rich ...

Recommended for you

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

Dulling cancer therapy's double-edged sword

January 17, 2018
Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.